Edition:
United States

Koninklijke DSM NV (RDSMY.PK)

RDSMY.PK on OTC Markets Group

15.81USD
28 Jul 2016
Change (% chg)

-- (--)
Prev Close
$15.81
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
67,821
52-wk High
$16.23
52-wk Low
$11.08

Summary

Name Age Since Current Position

Robert Routs

69 2011 Chairman of the Supervisory Board

Feike Sijbesma

57 2007 Chief Executive Officer and Chairman of the Managing Board

Ewald Kist

72 2008 Deputy Chairman of the Supervisory Board

Geraldine Matchett

43 2014 Chief Financial Officer, Member of the Managing Board

Dave Huizing

2012 Vice President Investor Relations

Dimitri de Vreeze

48 Member of the Management Board

Stefan Doboczky

49 2011 Member of the Managing Board

Stephan Tanda

51 2007 Member of the Managing Board

Tom de Swaan

70 2006 Member of the Supervisory Board

Victoria Haynes

68 2012 Member of the Supervisory Board

Pierre Hochuli

68 2005 Member of the Supervisory Board

Eileen Kennedy

68 2012 Member of the Supervisory Board

Pauline van der Meer Mohr

56 2011 Member of the Supervisory Board

Biographies

Name Description

Robert Routs

Dr. Robert J. Routs has served as Chairman of the Supervisory Board of Royal DSM NV since April 28, 2011. He was first appointed to the Supervisory Board, as Member, on March 31, 2010. He held various positions at Royal Dutch Shell before his retirement in 2008. He is currently Member of the Supervisory Board of Aegon NV, Royal KPN NV, Member of the Board of Directors of Aecom Technology Corporation, ATCO Group Ltd. and A.P. Moeller-Maersk Group. He is Member of the Company's Remuneration Committee and Chairman of the Company's Nominating Committee. He graduated from Eindhoven University with a degree in Chemical Engineering and with a PhD in Technology Science.

Feike Sijbesma

Mr. Feike Sijbesma has served as Chief Executive Officer and Chairman of the Managing Board of Royal DSM NV (DSM) since May 1, 2007. He was first appointed as Member of the Managing Board in July 2000. In 1987, he joined the Industrial Pharmaceuticals division of Gist-brocades, where was responsible for strategic planning and business development. From 1990 to 1993, he was appointed the division's Marketing and Sales Director. Thereafter he was given leadership of Savoury Ingredients and later on a business unit of Gist-brocades' Food Specialties Division. In 1995, he was made Director of that division and joined the Gist-brocades' Executive Committee. Following the acquisition by DSM in 1998 he became Director of the business group DSM Food Specialties. In 2000, Mr. Sijbesma joined DSM's Managing Board of Directors. He became Chairman of the Managing Board on May 1, 2007. In addition to this, Mr. Sijbesma also serves as Member of the Supervisory Board of De Nederlandsche Bank N.V. (Dutch Central Bank), Board Member of CEFIC (European Chemical Industry Council), Member of the Advisory Board of RSM Erasmus University and of ECP-EPN (Electronic Commerce Platform Netherlands).

Ewald Kist

Mr. Ewald Kist has served as Deputy Chairman of the Supervisory Board of Royal DSM NV since March 26, 2008. He was first appointed as Member of the Supervisory Board in 2004. He is currently retired. The last position he held was Chairman of the Managing Board of the ING Group. Mr. Ewald also serves as Member of Supervisory Board at Royal Philips Electronics N.V., Stage Entertainment and Moody's Investor Services. He is Chairman of the Company's Remuneration Committee and Member of the Company's Nomination Committee.

Geraldine Matchett

Dave Huizing

Mr. Dave Huizing has served as Vice President Investor Relations of Royal DSM NV since July 1, 2012. He started his career in DSM in 1985 as a lawyer. He held positions in Marketing & Sales and Key Account Management for DSM Materials businesses, before moving into general management positions, latterly at the Value Assurance Review team.

Dimitri de Vreeze

Stefan Doboczky

Mr. Stefan Doboczky has served as Member of the Managing Board of Royal DSM NV (DSM) since May 2011. Prior to joining the Company in 1998, he worked for 6 years at ARCO Chemicals in Austria and the United Kingdom. At DSM, Mr. Doboczky started in the DSM Fine Chemicals division, where he became Business Manager. In 2002 he moved to DSM Pharma Chemicals where he was Business Director from 2003 till 2006 based in the Netherlands. In 2006, he became Vice President and Business Unit Director China for DSM Anti-Infectives based in China. Since 2009 he has been Business Group Director of DSM Anti-Infectives. Since becoming a Member of the Managing Board of Koninklijke DSM NV in May 2011 he has been responsible for DSM's global activities in Pharma, as well as all DSM's activities in Asia. He is also CEO of DSM Sinochem Pharmaceutical, a joint venture between DSM and Sinochem in the area of anti-infectives. Mr. Doboczky holds a PhD degree from the University of Vienna and an MBA from IMD Business School in Lausanne, Switzerland.

Stephan Tanda

Mr. Stephan B. Tanda has served as Member of the Managing Board of Royal DSM NV since May 1, 2007. He studied Polymer Engineering at the Montanuniversitaet Leoben (University of Leoben), Austria, and Business Administration at the Wharton Business School of the University of Pennsylvania. He started his career in 1991 as Business Segment Manager Europe - Nomex/Kevlar Protective Apparel with DuPont in Switzerland. After assignments in Finance and Operations with DuPont in the United States, he was appointed Global Business Director, based in Luxembourg. In 1998 Mr. Tanda became Director Corporate Planning and later Vice President Strategic Planning & New Business Development Agriculture, Nutrition and Bio-Based Materials for DuPont in the United States. In 2000 he was appointed President of Protein Technologies International, Inc. and later President and Chief Executive Officer of The Solae Company, United States, a Joint Venture between DuPont and Bunge in the area of food innovation and food ingredient manufacturing. In 2004 he was appointed President and Chief Executive Officer of Freudenberg Nonwovens, a global group of industrial businesses, based in Weinheim, Germany, and Durham, United States. In addition to this, Mr. Tanda also serves as Board Member of EuropaBio (European Biotechnology Industries Association), Board Member of science industries (Swiss association for the chemical, pharmaceutical and biotech industries) and Board Member of Bio (US Biotechnology Industry Organization).

Tom de Swaan

Dr. Tom de Swaan has served as Member of the Supervisory Board of Koninklijke DSM NV since March 29, 2006. He is currently retired. The last position he held was Member of the Managing Board and Chief Financial Officer/Chief Risk Officer ABN AMRO. Dr. de Swaan also serves as Non-Executive Director of the Board of GlaxoSmithKline Plc and of the Board of Zurich Financial Services, Chairman of the Supervisory Board of Van Lanschot Bankiers N.V., Vice Chairman of the Supervisory Board of Royal Ahold N.V., Board Member of Royal Concertgebouw Orchestra and Member of the Board of Trustees of Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, as well as Chairman Advisory Board Rotterdam School of Management. Dr. de Swaan is Chairman of the Company's Audit Committee and Member of Remuneration Committee. He graduated from University of Amsterdam with a degree in Economics.

Victoria Haynes

Ms. Victoria F. Haynes has served as Member of the Supervisory Board of Royal DSM NV since May 11, 2012. The last position she held was President and CEO of the Research Triangle Institute International. Currently she serves as Member of the Board of Directors of PPG, Nucor, Ziptronix and, as of 2013, Axiall. She is Member of the Company's Audit Committee.

Pierre Hochuli

Mr. Pierre Hochuli has served as Member of the Supervisory Board of Royal DSM NV since April 6, 2005. He is former Chairman of the Board of Directors of Devgen N.V. and former Chairman of the Executive Committee, as well as former Member of the Board of Directors of Unibioscreen S.A. and former Member of the Board of Directors of Oncomethylome S.A. Mr. Hochuli also served as Venture Partner of Polytechnos Venture-Partners GmbH. He currently serves as Member of the Board of Directors of Domes of Silence Holdings Ltd. Mr. Hochuli is Member of the Company's Audit Committee and Corporate Social Responsibility Committee.

Eileen Kennedy

Ms. Eileen Kennedy has served as Member of the Supervisory Board of Royal DSM NV since May 11, 2012. She is Professor of Nutrition Friedman School of Nutrition Science and Policy at Tufts University in Boston (United States). She is also Dean of Nutrition Friedman School of Nutrition Science and Policy at Tufts University in Boston, Global Executive Director of the International Life Sciences Institute, Washington D.C. (United States), Deputy Under Secretary for Research, Education and Economics at the United States Department of Agriculture. Ms. Kennedy is Member of the Company's Corporate Social Responsibility Committee.

Pauline van der Meer Mohr

Ms. Pauline F.M. van der Meer Mohr has served as Member of the Supervisory Board of Royal DSM NV since April 28, 2011. She is currently President of the Executive Board of Erasmus University Rotterdam. Ms. van der Meer Mohr also serves as Member of the Supervisory Board of ASML N.V., Chair of the Supervisory Board of the Rotterdam School of Management, Member of the Supervisory Board of Nederlandse School voor Openbaar Bestuur, Director of the Hollandsche Maatschappij van Wetenschappen, Member of the Economic Development Board of Rotterdam and Member of the Duisenberg School of Finance Board. She is Chairman of Corporate Social Responsibility Committee.

Basic Compensation